HALO Precision Diagnostics: Company Research Report

Company Overview

• Name: HALO Precision Diagnostics™

• Mission: Saving lives with precision diagnostics through early disease detection and personalized care.

• Founding and Founders: No information is available.

• Key People in the Company:

• Michael Uhl - Chief Executive Officer

• Brian Axe - Chief Product Officer

• Aram Compeau - Chief Technology Officer

• Jeff Gerard - Head of HMG/Payor/Provider Relations

• Dr. John Feller - Chief Medical Officer

• Bernadette Greenwood, Ph.D. (c) - Chief Research Officer

• Dr. Ara Karamanian - Prostate Program Medical Director

• Dr. Stephen Scionti - Prostate Program Medical Director

• Dr. Raj Ayyagari - Interventional Radiologist

• Pedram Ilbeigi, D.O., FACS - CEO, HALO Men's Health Division and Medical Director, Clinical Services, Southern California

• Dr. Behzad Noorbehesht - HALO DX Fellow

• Dr. Jonathan Blevins - Board Certified Diagnostic Radiologist

• Dr. Christopher Hancock - Neuroscience Physician

• Dr. John R. Mehall - HALO DX Fellow

• Dr. Steven R. Gunberg - Director of Body and Cardiac Imaging

• Pat Schoof - VP of HR

• Headquarters: No specific location is mentioned.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Integrating imaging, screening, genetic testing, and therapies under one roof to personalize healthcare and early disease detection.

Products

• Precision Diagnostics

• High-level Description: Comprehensive diagnostic services covering various medical specializations.

• Key Features:

• Early detection of diseases

• Data-driven decisions for disease prevention and management

• Advanced Imaging Services

• High-level Description: Utilization of state-of-the-art imaging technologies for various health diagnostics.

• Key Features:

• MRI Scans

• CT Scans

• PET/CT Scans

• Whole Body MRI Screening

• Genetic Screening Kits

• High-level Description: Genetic testing for assessing risks and creating personalized health plans.

• Key Features:

• HALO PathWay™ for Prostate and Breast

• Polygenic Risk Score (PRS)

• Prostate Health Solutions

• High-level Description: Comprehensive prostate health screening and treatment programs.

• Key Features:

• TULSA-PRO and Laser Focal Therapy

• Minimally invasive treatments

• Prostate Cancer and BPH management

• Breast Health Solutions

• High-level Description: Advanced technologies for early detection and treatment of breast cancer.

• Key Features:

• 3D Mammography

• Abbreviated Breast MRI

Recent Developments

• Recent Developments in the Company:

• October 17, 2023: Collaborating with Bayer to advance contrast-enhanced MRI.

• October 12, 2023: Appointed Thomas P. Slavin, M.D., as Chief Scientific Officer.

• August 16, 2023: Appointed John Craighead as Chief Operating Officer and Chief Financial Officer.

• March 31, 2023: Introduced AI-powered CT technology in Coachella Valley.

• March 23, 2023: HALO Chico Breast Center designated as a Breast Imaging Center of Excellence.

• February 1, 2023: Launched the HALO Way™ for early disease detection.

• New Products Launched:

• New HALO PathWay™ for early detection of breast cancer.

• New Features Added to Existing Products: No information is available.

• New Partnerships:

• Collaborating with Bayer on the MRI clinical development program.

This report provides an extensive overview of HALO Precision Diagnostics based on the available data, focusing on their mission, key personnel, products, and recent industry developments.